DEMETER, J.; WEISINGER, J.; NAGY, Z. Mild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs) without interruption. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 13, n. 1, p. e2021022, 2021. DOI: 10.4084/mjhid.2021.022. Disponível em: https://mjhid.org/index.php/mjhid/article/view/4513. Acesso em: 22 oct. 2021.